Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. �Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). �He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. �Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. �For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. �This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. �His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. �Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. �To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Acute Leukemia and Lymphoma and blood and marrow/Stem cell transplant.Professional interests: Adolescent and Young Adults, Acute Lymphoblastic Leukemia. Personal interests: Skiing, biking, music. Dr. Asch is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Childhood Acute Myeloid Leukemia, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Michael Boyer is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Boyer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Hepatic Venoocclusive Disease with Immunodeficiency, Childhood Acute Myeloid Leukemia, and Bone Marrow Transplant.

Dr. McNeer is a Professor of Clinical Pediatrics at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology and is the Medical Director for Pediatric Hematology/Oncology at Primary Children's Hospital. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children's Hospital.After receiving her medical degree from New York University School of Medicine, Dr. McNeer completed her residency at Children's Memorial Hospital (now Lurie Children's Hospital), which is affiliated with Northwestern University Feinberg School of Medicine. She then completed her fellowship in Pediatric Hematology/Oncology/Stem Cell Transplant at Children's Memorial Hospital, and during her fellowship earned a master's degree in clinical investigation at Northwestern University Feinberg School of Medicine.Dr. McNeer is board-certified in Pediatrics and Pediatric Hematology and Oncology. She has authored over 25 peer-reviewed journal articles and 4 book chapters. Dr. McNeer has been an invited speaker at many national and international conferences and symposiums. She is a member of the American Society of Clinical Oncology, American Society of Hematology, as well as the American Society of Pediatric Hematology/Oncology and the Children's Oncology Group.Dr. McNeer's clinical expertise is in the treatment of children, adolescents, and young adults with hematologic malignancies such as leukemia and lymphoma, in particular those with high-risk and relapsed/refractory acute lymphoblastic leukemia. She has a leadership role within the Children's Oncology Group Acute Lymphoblastic Leukemia committee, and partners with colleagues in adult oncology to collaborate in developing treatment protocols and clinical trials for young adults with leukemia. Her research focus is on the design and implementation of clinical trials for patients with hematologic malignancies.Dr. McNeer is invested in improving overall treatment outcomes for children, adolescents, and young adults, while tailoring therapy and supportive care to individual patients in order to minimize toxicity and optimize quality of life. Dr. Mcneer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, Infantile Neutropenia, and Bone Marrow Aspiration.

Luke Maese is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Maese is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

acute leukemias, lymphomas and blood and marrow stem cell transplant. Dr. Hoda is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Phillip Barnette is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Barnette is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Leukemia, Hepatoblastoma, and Bone Marrow Aspiration.

Joshua Schiffman is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Schiffman is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Ewing Sarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, and Rhabdomyosarcoma.

Anupam Verma is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Verma is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Infantile Neutropenia, and Febrile Neutropenia.

Paul Shami is an Oncologist and a Hematologist in Salt Lake City, Utah. Dr. Shami is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Shami is currently accepting new patients.

Gabriela Motyckova is a Hematologist Oncology provider in Logan, Utah. Dr. Motyckova has been practicing medicine for over 20 years and is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Motyckova is currently accepting new patients.

Finn Petersen is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Petersen is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Petersen is currently accepting new patients.

Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children�s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children's Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship at St. Jude Children's Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children's Hospital in Delaware where he practiced for three years in pediatric hematology oncology. Dr. Mangum then joined the University of Utah in the Division of Pediatric Hematology Oncology at Primary Children's Hospital. Dr. Mangum's research interests have focused primarily on Acute Lymphoblastic Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum. Dr. Mangum is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rosai-Dorfman Disease, and Immune Thrombocytopenic Purpura (ITP).

Dr. Pyper is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Hematology team at the University of Utah and Primary Children's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine.Dr. Pyper completed his residency at the University of Vermont College of Medicine, University of Vermont Children's Hospital (Pediatrics). He completed his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota Medical School, University of Minnesota Masonic Children's Hospital.Dr. Pyper is board-certified in Pediatrics and Pediatric Hematology and Oncology. He is a member of many professional societies, including The American Society of Pediatric Hematology/Oncology, The American Society for Hematology and the American Society for Transplantation and Cellular Therapy. He has many years teaching experience and has previously been awarded teacher of the year by the associated pediatric residency program. He also takes great interest in patient and family education to make sure that patients and families understand their medical issues in an age-appropriate way so that they are able to participate in decision-making and advocate well for themselves and their loved ones.Dr. Pyper's clinical interests include the treatment of pediatric disorders including non-malignant hematology, disorders of hemostasis and thrombosis, sickle cell disease, red cell membrane defects and hemoglobinopathies as well as bone marrow failure syndromes.His primary research interests include congenital and acquired risk factors for abnormal bleeding and clotting in pediatric patients as well as improving access to needed health care resources for high-risk pediatric patients affected by hematologic diseases. Dr. Pyper is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hereditary Spherocytosis, Hemolytic Anemia, Acute Lymphoblastic Leukemia (ALL), and Congenital Hemolytic Anemia.

Mark Fluchel is a Pediatric Hematologist Oncology provider in Salt Lake City, Utah. Dr. Fluchel is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Non-Langerhans-Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis, Histiocytosis, and Reticulohistiocytoma.

Shiven Patel is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, and Orchiectomy. Dr. Patel is currently accepting new patients.

Ramiro Garzon is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Garzon is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Garzon is currently accepting new patients.

Srinivas Tantravahi is a Hematologist in Salt Lake City, Utah. Dr. Tantravahi is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), Myelofibrosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tantravahi is currently accepting new patients.

Fabiana Ostronoff is a Hematologist Oncology specialist and an Oncologist in Salt Lake City, Utah. Dr. Ostronoff is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ostronoff is currently accepting new patients.

Brian Mcclune is a Hematologist Oncology specialist and a Hematologist in Salt Lake City, Utah. Dr. Mcclune is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mcclune is currently accepting new patients.